1. Home
  2. SCPH vs RLGT Comparison

SCPH vs RLGT Comparison

Compare SCPH & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • RLGT
  • Stock Information
  • Founded
  • SCPH 2013
  • RLGT 2001
  • Country
  • SCPH United States
  • RLGT United States
  • Employees
  • SCPH N/A
  • RLGT N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • RLGT Oil Refining/Marketing
  • Sector
  • SCPH Health Care
  • RLGT Consumer Discretionary
  • Exchange
  • SCPH Nasdaq
  • RLGT Nasdaq
  • Market Cap
  • SCPH 299.0M
  • RLGT 282.9M
  • IPO Year
  • SCPH 2017
  • RLGT N/A
  • Fundamental
  • Price
  • SCPH $5.67
  • RLGT $6.03
  • Analyst Decision
  • SCPH Buy
  • RLGT Strong Buy
  • Analyst Count
  • SCPH 3
  • RLGT 1
  • Target Price
  • SCPH $12.00
  • RLGT $8.00
  • AVG Volume (30 Days)
  • SCPH 2.0M
  • RLGT 333.9K
  • Earning Date
  • SCPH 11-12-2025
  • RLGT 11-11-2025
  • Dividend Yield
  • SCPH N/A
  • RLGT N/A
  • EPS Growth
  • SCPH N/A
  • RLGT 118.75
  • EPS
  • SCPH N/A
  • RLGT 0.35
  • Revenue
  • SCPH $49,969,000.00
  • RLGT $902,696,000.00
  • Revenue This Year
  • SCPH $104.30
  • RLGT $7.61
  • Revenue Next Year
  • SCPH $76.06
  • RLGT N/A
  • P/E Ratio
  • SCPH N/A
  • RLGT $17.15
  • Revenue Growth
  • SCPH 107.79
  • RLGT 12.49
  • 52 Week Low
  • SCPH $1.94
  • RLGT $5.44
  • 52 Week High
  • SCPH $6.28
  • RLGT $7.94
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.40
  • RLGT 46.75
  • Support Level
  • SCPH $5.64
  • RLGT $5.82
  • Resistance Level
  • SCPH $5.65
  • RLGT $6.11
  • Average True Range (ATR)
  • SCPH 0.03
  • RLGT 0.15
  • MACD
  • SCPH -0.02
  • RLGT -0.01
  • Stochastic Oscillator
  • SCPH 66.67
  • RLGT 54.44

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About RLGT Radiant Logistics Inc.

Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.

Share on Social Networks: